制度・支援
指定難病 — No.16

クロウ・深瀬症候群

検索語 POEMS Syndrome ・ 最終更新 2026-09-17 14:02 ・ 最新に更新

Data Sheet
指定 No.16
Src PubMed · CT.gov · jRCT

これは医療アドバイスではありません。診断・治療の判断は必ず主治医にご相談ください。論文や治験は「今わかっている研究の状況」を示すもので、効果を保証するものではありません。

( 01 )EVIDENCE / PUBMED · 5件

世界の論文

直近の研究を、やさしい日本語で

各論文の見出しにある「確からしさ」は、その研究がどれくらい信頼できるかの目安です。「理論段階」はまだ仮説に近く、下にいくほど多くの患者で検証されていて、「メタ解析」がもっとも信頼できます。

症例報告
MK-01 · PMID 42736824

A case report on the co-presentation of pituitary abscess and POEMS-like syndrome

Abstract / 原文

RATIONALE: POEMS syndrome is a rare paraneoplastic syndrome, manifesting with progressive distal polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes, which has multisystem manifestations and chronic cytokine overproduction. Pituitary abscess is also a rare life-threatening disease that could lead to panhypopituitarism. We report a case of pituitary abscess with high suspicion of POEMS syndrome, which to our knowledge has not been reported previously. PATIENT CONCERNS: The co-presentation of pituitary abscess and POEMS-like syndrome is rare and its clinical manifestations are complex, making it easy to miss diagnosis and misdiagnosis. Long-term disease management and follow-up is crucial under this condition. DIAGNOSIS: The patient was admitted to outside hospital due to headache, impaired consciousness, and fever since April 2024. Initial test results suggested neuroinfection. Endocrine abnormalities revealed diabetes insipidus and panhypopituitarism, including central hypocortisolism, hypogonadism, and hyperprolactinemia. Pituitary-enhanced MRI revealed abnormal pituitary signals on T1- and T2-weighted images, with peripheral rim enhancement noted after gadolinium injection. Further examination revealed lymphadenopathy, polyneuropathy, skin changes, monoclonal gammopathy (lamda chain, M-protein), ascites, meeting the diagnostic criteria for POEMS syndrome. Bone marrow core biopsy showed no malignancy. Despite the normal VEGF level, the patient was diagnosed with pituitary abscess and possibly POEMS syndrome due to other clinical presentations. INTERVENTIONS: The patient underwent transsphenoidal resection of the pituitary gland lesions, antibiotic treatment and hormone replacement therapy with hydrocortisone and desmopressin. OUTCOMES: At 9 months of follow-up, the patient experienced recurrent fever, headache, and diabetes insipidus after discontinuation of hormone therapy. LESSONS: The diagnosis of complex comorbidities is based on the combination of clinical manifestations and laboratory tests, multidisciplinary and comprehensive assessment are of great significance for this disease.

Journal
Medicine(2026 Sep)
Authors
3名
Type
Journal Article, Case Reports
PubMedで原文を見る
症例報告
MK-02 · PMID 42723812

POEMS syndrome presenting as presumed chronic glomerulonephritis with a 1-year delay in diagnosis: a case report

Abstract / 原文

BACKGROUND: Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal protein, Skin changes (POEMS) syndrome is a rare paraneoplastic disorder driven by an underlying plasma cell dyscrasia. While renal involvement is common, it typically manifests after neurological or dermatological symptoms. Chronic glomerulonephritis-like manifestations as the sole initial feature for a prolonged period are exceptionally rare and can lead to delayed diagnosis. CASE PRESENTATION: A 38-year-old woman presented with a 1-year history of foamy urine and a 1-week history of lower limb muscle pain. She had previously been treated with irbesartan for presumed chronic glomerulonephritis. Two months prior to admission, she developed lower limb numbness, followed by progressive muscle pain. Physical examination revealed cervical lymphadenopathy and left-sided cardiomegaly. Laboratory investigations demonstrated proteinuria, mild renal impairment, and a serum monoclonal immunoglobulin A (IgA)-λ protein on immunofixation electrophoresis. Nerve conduction studies confirmed severe demyelinating polyneuropathy. Imaging revealed pericardial effusion, splenomegaly, and bilateral renal enlargement. Following multidisciplinary consultation, subsequent investigations revealed markedly elevated serum vascular endothelial growth factor (VEGF) and patchy, slightly high-density shadows in bilateral iliac bones on abdominal computed tomography (CT), which supported the definitive diagnosis of POEMS syndrome. At follow-up, the patient was initiated on lenalidomide and dexamethasone therapy and is currently undergoing autologous stem cell transplantation at a tertiary care center, showing significant symptomatic improvement. CONCLUSION: In patients with an unexplained chronic glomerulonephritis-like presentation that is refractory to standard therapy, POEMS syndrome should be considered in the differential diagnosis, even in the absence of typical skin or bone changes. Early serum immunofixation and VEGF assessment are critical for avoiding a delayed diagnosis.

Journal
Frontiers in medicine(2026)
Authors
3名
Type
Case Reports, Journal Article
PubMedで原文を見る
不明
MK-03 · PMID 42706164

[Treatment of POEMS syndrome with the DRd regimen in an elderly, frail, high-risk patient: a case report]

Journal
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi(2026 Jun)
Authors
3名
Type
Journal Article
PubMedで原文を見る
症例報告
MK-04 · PMID 42616910

POEMS syndrome with atypical presentation: A rare case

Abstract / 原文

POEMS is an uncommon paraneoplastic plasma cell disorder known with the expansion of polyneuropathy, organomegaly, endocrine abnormalities, M-band, and skin changes. We report a patient presenting with monoarthritis and weight loss for 5 months, who was treated empirically for tuberculous arthritis and later developed debilitating axonal polyneuropathy due to delayed diagnosis. POEMS/Plasma cell dyscrasias rarely involve joints, and this case highlights this unique presentation of POEMS syndrome. Bone biopsy from the affected joint revealed the diagnosis. Chronic large-joint monoarthritis with systemic symptoms, mimicking tuberculous arthritis, and polyneuropathy is a unique combination-so clinicians should consider an underlying plasma cell dyscrasia/POEMS to avoid delayed diagnosis.

Journal
Journal of postgraduate medicine(2026 Jul)
Authors
4名
Type
Journal Article, Case Reports
PubMedで原文を見る
観察研究
MK-05 · PMID 42611186

Polyneuropathy, Organomegaly, Endocrinopathy, M-Protein, and Skin Changes (POEMS) Syndrome With Characteristic Muscle Biopsy Findings and Without M-Protein

Abstract / 原文

INTRODUCTION: POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal gammopathy, and Skin changes) syndrome is a rare paraneoplastic disorder driven by proinflammatory cytokines, particularly vascular endothelial growth factor (VEGF), which promotes multisystemic angiogenesis and inflammation. It is frequently misdiagnosed as Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) due to overlapping features. CASE REPORT: A 63-year-old woman was referred for presumed CIDP unresponsive to IVIG and steroids. Her clinical course was notable for 100-pound weight loss, papilledema, skin changes, thrombocytosis, thromboembolisms, hemi-diaphragmatic paralysis, organomegaly/lymphadenopathy, and negative bone marrow and lymph node biopsies. POEMS was diagnosed based on repeat electrodiagnostic testing, elevated VEGF and prolactin, and nerve/muscle biopsies showing endomysial edema and angiogenesis. Notably, no monoclonal protein (M-protein) was identified. Treatment with lenalidomide and dexamethasone resulted in significant clinical improvement. CONCLUSION: Paraprotein-negative POEMS syndrome should be considered in refractory CIDP, especially in the presence of skin changes, endocrinopathy, papilledema, and thrombocytosis. VEGF levels and nerve/muscle biopsy findings are critical diagnostic tools in patients with high clinical suspicion who lack monoclonal gammopathy. Muscle biopsy may increase the diagnostic yield by revealing characteristic vascular proliferation, a feature previously described in nerve biopsies of patients with POEMS syndrome.

Journal
The neurologist(2026 Aug)
Authors
5名
Type
Journal Article
PubMedで原文を見る
( 02 )TRIALS / JAPAN · 0件

日本で参加できる治験

現在 募集中のもの

日本で現在募集中の治験は見つかりませんでした。下の公式レジストリで条件を変えると見つかる場合があります。
( 03 )REGISTRY / jRCT

治験をもっと探す

日本の公式レジストリで全件を確認

上の一覧は ClinicalTrials.gov の一部です。日本国内の治験の多くは、日本の公式レジストリ jRCT にのみ登録されています。下記から最新の全件を確認できます。

jRCT で検索日本の臨床研究実施計画 公開システム「対象疾患名」に クロウ・深瀬症候群 を入力し、「募集状況」で 募集中 にチェックして検索します。ClinicalTrials.gov で全件を見る世界最大の治験データベース(英語)「クロウ・深瀬症候群・日本・募集中」の条件で一覧が開きます。

※ jRCTは自動の大量データ取得を禁じているため、本サービスは自動収集せず、ご自身が公式サイトで検索できるリンクでご案内しています(規約順守)。

お金・介護・制度クロウ・深瀬症候群の療養に使えるかもしれない公的サポートを調べる医療費・生活費・介護の支援制度と相談先を、あなたの状況に合わせてご案内(回答は端末内で完結)
( 04 )SUPPORT

患者会・相談窓口

一人で抱え込まないでください

同じ病気の患者・家族とつながる、制度や生活の相談をする、といったときの窓口です。

全国の相談先

※ お住まいの都道府県の「難病相談支援センター」でも、医療費助成や療養生活の相談ができます(難病情報センターから探せます)。